（文章来源：证券日报） 证券日报网讯 8月6日晚间，安旭生物发布公告称，公司第二届监事会第十六次会议审议通过了《关于 取消监事会、修订并办理工商变更登记及修订相关制度的议案》等多项议案。 ...

（文章来源：证券日报） 证券日报网讯 8月6日晚间，安旭生物发布公告称，公司第二届董事会第十八次会议审议通过了《关于 董事会换届选举暨提名第三届董事会非独立董事候选人的议案》等多项议案。 ...

Group 1 - The company announced the organization of a staff representative meeting on August 6, 2025, to elect Mr. Dong Wenkun as the employee representative director of the third board of directors [2] - Mr. Dong Wenkun's term will be consistent with that of the company's third board of directors [2]

证券日报网讯 8月6日晚间，安旭生物发布公告称，公司于2025年8月6日召开第二届董事会第十八次会 议和第二届监事会第十六次会议，审议通过了《关于使用部分暂时闲置自有资金进行现金管理的议 案》，同意公司在保证公司正常经营运作资金需求和资金安全的前提下，使用不超过人民币400， 000.00万元的部分暂时闲置自有资金进行现金管理。本事项尚需提交公司2025年第一次临时股东大会审 议。有效期自2025年9月18日起12个月内有效。在上述额度及期限内，资金可以循环滚动使用。 （文章来源：证券日报） ...

Group 1 - Xianhe Co., Ltd. plans to invest approximately 11 billion yuan in an integrated high-performance paper-based material project in Sichuan Province, with an expected annual production capacity of 800,000 tons of bamboo pulp and 1.2 million tons of high-performance paper-based materials [1] - Funi Co., Ltd. intends to invest about 7.802 billion yuan in the construction of a pumped storage power station project in Nanan, Fujian Province, which will enhance the company's clean energy capacity [6] - Zhongchuan Technology's subsidiary plans to invest approximately 5.712 billion yuan in a 1.3 million kilowatt wind power project in Xinjiang [9] Group 2 - Shennong Group reported a sales revenue of 327 million yuan from the sale of 174,700 pigs in July 2025, with an average selling price of 14.73 yuan per kilogram, reflecting a 2.65% increase from June 2025 [2] - CITIC Securities' subsidiary, Huaxia Fund, achieved a net profit of 1.123 billion yuan in the first half of 2025, with total assets under management reaching 2.8512 trillion yuan [5] - Jiangnan Water Affairs plans to publicly transfer an 8% stake in Pudong Village Bank, with a minimum transfer price of approximately 12.548 million yuan [4] Group 3 - Anxu Bio plans to utilize up to 4 billion yuan of temporarily idle funds for cash management [8] - Changsheng Bearing has set the inquiry transfer price at 61.82 yuan per share for its upcoming share transfer [11] - Electric Connection Technology intends to acquire a 39% stake in its subsidiary, Aimers, for 180 million yuan, increasing its ownership from 51% to 90% [12]

证券代码：688075 证券简称：安旭生物 公告编号：2025-017 杭州安旭生物科技股份有限公司 关于董事会换届选举的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 杭州安旭生物科技股份有限公司（以下简称"公司"或"安旭生物"）第二届董事 会任期即将届满。根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上海证券交易所科创板股票上市规则》等法律、法规以及《公司章程》等相关规 定，公司开展董事会换届选举工作，现将具体情况公告如下： 一、 董事会换届选举情况 换届选举暨提名第三届董事会非独立董事候选人的议案》和《关于董事会换届选举 暨提名第三届董事会独立董事候选人的议案》。 经公司董事会提名委员会对公司第三届董事会董事候选人的任职资格审查，董 事会同意提名凌世生先生、姜学英女士、黄银钱先生为公司第三届董事会非独立董 事候选人；同意提名戴文涛先生、宋达峰先生、程乐先生为公司第三届董事会独立 董事候选人，其中戴文涛先生为会计专业人士。上述董事候选人经公司股东大会审 议通过后，将与经公司职工代表大会选举产生的 1 ...

证券代码：688075 证券简称：安旭生物 公告编号：2025-017 杭州安旭生物科技股份有限公司 关于董事会换届选举的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 杭州安旭生物科技股份有限公司（以下简称"公司"或"安旭生物"）第二届董事 会任期即将届满。根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上海证券交易所科创板股票上市规则》等法律、法规以及《公司章程》等相关规 定，公司开展董事会换届选举工作，现将具体情况公告如下： 一、董事会换届选举情况 2025 年 8 月 6 日，公司第二届董事会第十八次会议审议通过了《关于董事会 换届选举暨提名第三届董事会非独立董事候选人的议案》和《关于董事会换届选举 暨提名第三届董事会独立董事候选人的议案》。 经公司董事会提名委员会对公司第三届董事会董事候选人的任职资格审查，董 事会同意提名凌世生先生、姜学英女士、黄银钱先生为公司第三届董事会非独立董 事候选人；同意提名戴文涛先生、宋达峰先生、程乐先生为公司第三届董事会独立 董事候选人，其中戴文涛先生为会计专业人士 ...

Group 1 - The company held its 16th meeting of the second supervisory board, with all three supervisors present, ensuring compliance with relevant laws and regulations [1] - The supervisory board approved the proposal to cancel the supervisory board and amend the company's articles of association, transferring the supervisory responsibilities to the audit committee of the board of directors [1][2] - The proposal to use part of the temporarily idle self-owned funds for cash management was also approved, allowing the company to invest up to RMB 4 billion in safe and liquid financial products [2][3] Group 2 - The supervisory board emphasized that it will continue to fulfill its supervisory duties until the shareholders' meeting approves the cancellation of the supervisory board, ensuring the protection of the company's and shareholders' interests [2] - The cash management proposal is aimed at improving the efficiency and return of fund usage while ensuring the company's normal operations and fund safety [3]

General Principles - The implementation rules for the cumulative voting system aim to improve the corporate governance structure of Hangzhou Anxu Biotechnology Co., Ltd. and protect the interests of minority shareholders [1][2] - The cumulative voting system allows shareholders to allocate their voting rights according to their preferences when electing directors, with each share granting the same number of votes as the number of directors to be elected [1][2] Nomination of Director Candidates - The board of directors and shareholders holding 3% or more of the company's shares have the right to propose candidates for non-independent directors [2][3] - Candidates must submit detailed personal information and a written commitment to accept the nomination and fulfill their duties if elected [2][3] Election and Voting of Directors - The election process includes specific steps for calculating votes under the cumulative voting system, ensuring that independent and non-independent directors are elected separately [3][4] - The number of elected directors must comply with the company's articles of association, and candidates must receive more than half of the valid voting rights to be elected [4][5] Election Results and Follow-up - If the number of elected candidates exceeds the number of available positions, those with the highest votes will be elected, and if there are ties, a second round of voting will occur [5] - If the elected directors do not meet the required number, a follow-up election will be held within two months after the meeting [5] Additional Provisions - The rules state that the meeting host must explain the cumulative voting system to ensure shareholders vote correctly [6] - The rules will take effect after being approved by the shareholders' meeting and will be interpreted by the board of directors [6]

杭州安旭生物科技股份有限公司 投资者关系管理制度 杭州安旭生物科技股份有限公司 投资者关系管理制度 （2025 年 8 月修订） （一）透露或者发布尚未公开的重大事件信息，或者与依法披露的信息相冲 突的信息； 第一章 总 则 第一条 为了加强杭州安旭生物科技股份有限公司（以下简称"公司"）与投 资者之间的信息沟通，完善公司治理结构，切实保护投资者特别是社会公众投资 者的合法权益，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司投资者关 系管理工作指引》、《上海证券交易所科创板股票上市规则》、《杭州安旭生物 科技股份有限公司章程》（以下简称"公司章程"）及其他有关法律、法规的规 定，结合公司实际情况，制定本制度。 第二条 投资者关系管理是指公司通过便利股东权利行使、信息披露、互动 交流和诉求处理等工作，加强与投资者及潜在投资者之间的沟通，增进投资者对 上市公司的了解和认同，以提升公司治理水平和企业整体价值，实现尊重投资者、 回报投资者、保护投资者目的的相关活动。 第三条 公司投资者关系管理工作应严格遵守《公司法》、《证券法》等有 关法律、法 ...